Clinical Research Directory
Browse clinical research sites, groups, and studies.
PROGAIN Trial in Gastric Cancer Surgery
Sponsor: Soonchunhyang University Hospital
Summary
This randomized study will evaluate whether protein-enriched parenteral nutrition improves early postoperative recovery in patients undergoing gastrectomy for gastric cancer. Participants will be assigned to receive either protein-enriched parenteral nutrition or standard parenteral nutrition during the perioperative period. The primary outcome is nitrogen balance on postoperative day 5. Secondary outcomes include postoperative complications, recovery of oral intake, and short-term changes in nutritional status and body composition.
Official title: The PROGAIN Trial : A Randomized Study of Protein-enriched Parenteral Nutrition on Nitrogen Balance and Recovery in Perioperative Gastric Cancer Surgery
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2026-02-13
Completion Date
2028-03
Last Updated
2026-03-25
Healthy Volunteers
No
Conditions
Interventions
Protein-enriched peripheral parenteral nutrition (Winuf A+ injection)
A novel, high-amino acid peripheral parenteral nutrition formulation (Winuf A+ injection; JW Pharmaceutical) designed to provide optimal protein delivery with lower glucose load. Administered intravenously.
Standard peripheral parenteral nutrition (Winuf injection)
A conventional, standard 3-chamber peripheral parenteral nutrition formulation (Winuf injection; JW Pharmaceutical). Administered intravenously.
Locations (1)
Soonchunhyang University Cheonan Hospital
Cheonan, Chungcheongnam-do, South Korea